SU1025327A3 - Способ получени производных арилоксиаминобутанола или их солей - Google Patents

Способ получени производных арилоксиаминобутанола или их солей Download PDF

Info

Publication number
SU1025327A3
SU1025327A3 SU752108001A SU2108001A SU1025327A3 SU 1025327 A3 SU1025327 A3 SU 1025327A3 SU 752108001 A SU752108001 A SU 752108001A SU 2108001 A SU2108001 A SU 2108001A SU 1025327 A3 SU1025327 A3 SU 1025327A3
Authority
SU
USSR - Soviet Union
Prior art keywords
compounds
general formula
salts
alkyl
compound
Prior art date
Application number
SU752108001A
Other languages
English (en)
Russian (ru)
Inventor
Харшаньи Кальман
Корбонитш Деже
Молнар Эржебет
Сеги Иожеф
Original Assignee
Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие) filed Critical Хиноин Дьедьсер Еш Ведьесети Термекек Дьяра Рт (Инопредприятие)
Application granted granted Critical
Publication of SU1025327A3 publication Critical patent/SU1025327A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU752108001A 1974-02-20 1975-02-19 Способ получени производных арилоксиаминобутанола или их солей SU1025327A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1449A HU169464B (es) 1974-02-20 1974-02-20

Publications (1)

Publication Number Publication Date
SU1025327A3 true SU1025327A3 (ru) 1983-06-23

Family

ID=10994508

Family Applications (1)

Application Number Title Priority Date Filing Date
SU752108001A SU1025327A3 (ru) 1974-02-20 1975-02-19 Способ получени производных арилоксиаминобутанола или их солей

Country Status (22)

Country Link
JP (1) JPS5929063B2 (es)
AT (1) AT339281B (es)
BE (1) BE825745A (es)
BG (2) BG26366A3 (es)
CA (1) CA1074338A (es)
CH (1) CH619684A5 (es)
CS (1) CS199578B2 (es)
DD (1) DD119414A5 (es)
DE (1) DE2506355C2 (es)
DK (1) DK141935B (es)
ES (2) ES434784A1 (es)
FI (1) FI61304C (es)
FR (1) FR2261001B1 (es)
GB (1) GB1457086A (es)
HU (1) HU169464B (es)
IL (1) IL46634A (es)
NL (1) NL182698C (es)
NO (1) NO141754C (es)
PL (2) PL99025B1 (es)
SE (1) SE433935B (es)
SU (1) SU1025327A3 (es)
YU (2) YU36916B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48309A (en) * 1974-10-25 1980-01-31 Robins Co Inc A H 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions containing them
DE3373466D1 (de) * 1982-06-10 1987-10-15 Beecham Wuelfing Gmbh & Co Kg Amine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
GB1245148A (en) * 1968-11-18 1971-09-08 Pfizer Ltd Propanolamine derivatives
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
CH561174A5 (es) * 1969-09-24 1975-04-30 Ici Ltd

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Патент Англии №1264128, кл. С 2 е, опублик. 1972. 2.. Машковский М.Д. Лекарственные средства. Т. 1. М., Медицина, 1972, с.234. *

Also Published As

Publication number Publication date
YU167681A (en) 1983-04-27
CA1074338A (en) 1980-03-25
FR2261001A1 (es) 1975-09-12
DK141935B (da) 1980-07-21
SE433935B (sv) 1984-06-25
YU37375A (en) 1982-06-18
JPS5929063B2 (ja) 1984-07-18
FI61304B (fi) 1982-03-31
DD119414A5 (es) 1976-04-20
NL182698C (nl) 1988-05-02
NO750566L (es) 1975-08-21
NL7501951A (nl) 1975-08-22
CS199578B2 (en) 1980-07-31
NO141754C (no) 1980-05-07
YU37116B (en) 1984-08-31
FI750443A (es) 1975-08-21
SE7501801L (es) 1975-08-21
YU36916B (en) 1984-08-31
ATA114075A (de) 1977-02-15
GB1457086A (en) 1976-12-01
AT339281B (de) 1977-10-10
DE2506355A1 (de) 1975-08-21
ES453326A1 (es) 1977-11-16
IL46634A (en) 1979-01-31
FI61304C (fi) 1982-07-12
ES434784A1 (es) 1977-03-16
JPS50117728A (es) 1975-09-16
NO141754B (no) 1980-01-28
FR2261001B1 (es) 1978-07-21
PL99023B1 (pl) 1978-06-30
DE2506355C2 (de) 1983-10-06
BG26367A4 (bg) 1979-03-15
DK60875A (es) 1975-10-20
BG26366A3 (bg) 1979-03-15
BE825745A (fr) 1975-06-16
HU169464B (es) 1976-11-28
DK141935C (es) 1980-12-08
PL99025B1 (pl) 1978-06-30
IL46634A0 (en) 1975-04-25
CH619684A5 (en) 1980-10-15

Similar Documents

Publication Publication Date Title
EP0150263B1 (de) Derivate der cis, endo-2-Azabicyclo-[3.3.0]-octan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
EP0090362A2 (de) Neue Derivate von Cycloalka(c)pyrrol-carbonsäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung sowie neue Cycloalka(c)pyrrol-carbonsäuren als Zwischenstufen und Verfahren zu deren Herstellung
EP0109020A2 (de) Neue Derivate tricyclischer Aminosäuren, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung, sowie neue bicyclische Aminosäuren als Zwischenstufen und Verfahren zu deren Herstellung
DE2455353C3 (de) Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben
DE2418344A1 (de) Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung
SU1025327A3 (ru) Способ получени производных арилоксиаминобутанола или их солей
JPS6251A (ja) シス，エンド−２−アザビシクロ〔３．３．０〕オクタン−３−カルボン酸誘導体およびその製法
US3445518A (en) P-acylphenylethylamines
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
US2625567A (en) 1-benzyloxy-2-alkylaminoindanes
DE1238898B (de) Verfahren zur Herstellung von Styrylaethanolaminen
US4563477A (en) Process for the preparation of alpha-(N-pyrrolyl)-derivative acids, the salts and esters thereof; alpha-(N-pyrrolyl)-phenylacetic acids, the esters thereof, pharmaceutical compositions containing them and therapeutical applications thereof
DE2062055C3 (de) Propanolamin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0061406B1 (fr) Dérivés d'acide benzamido-alkyl-hydroxamique, procédé de préparation et composition thérapeutique
US2970159A (en) Hydrazine derivatives
RU2816900C1 (ru) Применение 5-арил-4-ароил-3-гидрокси-1-карбоксиметил-3-пирролин-2-онов в качестве анальгетических средств
DE2827805A1 (de) Alpha-vinyl-aminosaeuren und verfahren zu ihrer herstellung
US3374265A (en) Diphenyl hydroxy carbamate compounds
US4143140A (en) Morpholine carboxamides and use thereof
DE2725245A1 (de) Methylaminderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische oder veterinaermedizinische zusammensetzungen
EP0019739B1 (de) 2-Aminoalkyl-5-pyridinole, Verfahren zu ihrer Herstellung und pharmazeutische Präparate die diese Verbindungen enthalten
US4172150A (en) Cardiac stimulants
DE2137538A1 (de) Methoxyaminderivate und ihre Salze sowie ihre Verwendimg und Verfahren zur Herstellung derselben
RU1797489C (ru) Способ лечени респираторных болезней тел т
EP0024616B1 (de) 1-(3'-Acyloxyphenyl)-2-aminoethanole, deren Säureadditionssalze, diese enthaltende Arzneimittel, sowie Verfahren zu ihrer Herstellung